TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.
In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
TFF Pharmaceuticals Corporate Overview – March 2020
May 14, 2020
TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020
May 7, 2020
TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting
April 30, 2020